Osteoarthritis is one of the most common joint diseases in the world, especially among older adults. As people age, years of movement, weight-bearing, and minor injuries slowly wear down their joints.
The condition mainly affects the knees, hips, hands, and spine, making everyday activities such as walking, standing, or climbing stairs painful and difficult. For many people, osteoarthritis gradually reduces independence and quality of life.
At the center of osteoarthritis is cartilage, the smooth, rubbery tissue that covers the ends of bones inside a joint. Cartilage acts like a cushion and allows bones to glide smoothly against each other. Over time, repeated stress and low-level inflammation can cause this cartilage to thin and break down.
When cartilage wears away, bones begin to rub together, leading to pain, stiffness, swelling, and reduced movement. As the disease progresses, some people eventually require knee or hip replacement surgery to restore mobility.
Because joint replacement surgery is expensive, involves long recovery periods, and carries certain risks, researchers have been searching for ways to slow osteoarthritis before it reaches this advanced stage.
A recent study has offered new hope by suggesting that a small daily dose of a long-used anti-inflammatory drug may help delay or even reduce the need for joint replacement surgery.
The study focused on colchicine, a medication that has been used for many years to treat gout and other inflammatory conditions. Colchicine works by calming the body’s inflammatory response.
Although inflammation plays a role in osteoarthritis, colchicine has not traditionally been recommended for this condition because its long-term effects on joint health were not fully understood.
Researchers from the Netherlands, including specialists from Sint Maartenskliniek and Radboud University Medical Center, examined data from a large international trial known as LoDoCo2. This trial originally focused on heart disease, but it also provided valuable information about joint health over time.
The study included 5,522 adults between the ages of 35 and 82. Participants were recruited from 43 medical centers across Australia and the Netherlands.
They were randomly assigned to take either a low daily dose of colchicine, just 0.5 milligrams, or a placebo pill with no active ingredients. This random assignment helped ensure that the results were fair and reliable. On average, participants were followed for just over two years.
During the study period, researchers tracked how many people went on to receive total knee or hip replacement surgery. The results showed a noticeable difference between the two groups.
Among those taking colchicine, only 2.5 percent needed joint replacement surgery. In comparison, 3.5 percent of people in the placebo group required these operations.
While this difference may appear small at first glance, it is meaningful when applied to large populations. The findings suggest that colchicine may help slow the damage that leads to severe joint failure, allowing people to maintain their natural joints for longer.
Even delaying surgery by a few years can significantly improve a person’s quality of life and reduce strain on healthcare systems.
The researchers also noticed that the protective effect of colchicine appeared stronger in men than in women. However, the study was not designed to fully explain this difference. More research will be needed to determine whether women experience the same level of benefit or whether dosage and treatment strategies should differ.
Despite the promising results, experts caution that colchicine is not yet ready to be widely recommended for osteoarthritis.
Although it has been used safely for many years in other conditions, long-term use specifically for osteoarthritis still needs to be studied more carefully. Researchers want to better understand potential side effects and whether the benefits continue over longer periods.
If future studies confirm these findings, colchicine could become a valuable addition to osteoarthritis treatment. It may offer a simple and affordable way to slow disease progression, reduce pain, and help people stay active for longer.
Most importantly, it could reduce the number of knee and hip replacement surgeries, which can be physically and emotionally demanding for patients.
For now, this research provides hope to millions of people living with osteoarthritis. It shows that even well-known medications can find new uses and that ongoing research continues to open new paths for managing long-term joint disease.
If you care about bone health, please read studies that plant-based diets can harm your bone health without these nutrients, and this bone problem may strongly increase COVID-19 death risk.
For more health information, please see recent studies that too much of this vitamin may increase your risk of bone fractures, and results showing this type of exercise may protect your bone health, slow down bone aging.
Copyright © 2026 Knowridge Science Report. All rights reserved.
